These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 28900175)
1. Dynamic and Kinetic Elements of µ-Opioid Receptor Functional Selectivity. Kapoor A; Martinez-Rosell G; Provasi D; de Fabritiis G; Filizola M Sci Rep; 2017 Sep; 7(1):11255. PubMed ID: 28900175 [TBL] [Abstract][Full Text] [Related]
2. How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways. Schneider S; Provasi D; Filizola M Biochemistry; 2016 Nov; 55(46):6456-6466. PubMed ID: 27778501 [TBL] [Abstract][Full Text] [Related]
3. Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of Kapoor A; Provasi D; Filizola M Mol Pharmacol; 2020 Oct; 98(4):475-486. PubMed ID: 32680919 [TBL] [Abstract][Full Text] [Related]
4. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform. Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045 [TBL] [Abstract][Full Text] [Related]
5. 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion. Zhang Y; Williams DA; Zaidi SA; Yuan Y; Braithwaite A; Bilsky EJ; Dewey WL; Akbarali HI; Streicher JM; Selley DE ACS Chem Neurosci; 2016 Mar; 7(3):297-304. PubMed ID: 26716358 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591 [TBL] [Abstract][Full Text] [Related]
7. Molecular Dynamics Simulations to Investigate How PZM21 Affects the Conformational State of the μ-Opioid Receptor Upon Activation. Zhao Z; Huang T; Li J Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630190 [TBL] [Abstract][Full Text] [Related]
8. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain. Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176 [TBL] [Abstract][Full Text] [Related]
9. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation. Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617 [TBL] [Abstract][Full Text] [Related]
10. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance. Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067 [TBL] [Abstract][Full Text] [Related]